Publications by authors named "Birgit Jaschke"

Claim this Profile
R
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
Julinda Mehilli, Adnan Kastrati, Rainer Wessely, Alban Dibra, Jörg Hausleiter, Birgit Jaschke

Circulation· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Birgit Jaschke, Cornelia Michaelis, Stefan Milz, Michael Vogeser, Thomas Mund

Cardiovasc Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Rainer Wessely, Jörg Hausleiter, Cornelia Michaelis, Birgit Jaschke, Michael Vogeser

Arterioscler Thromb Vasc Biol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice.
Sabine Merl, Cornelia Michaelis, Birgit Jaschke, Marc Vorpahl, Stefan Seidl

Circulation· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Birgit Jaschke, Stefan Milz, Michael Vogeser, Cornelia Michaelis, Marc Vorpahl

FASEB J· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia.
Rainer Wessely, Ludger Hengst, Birgit Jaschke, Franziska Wegener, Thomas Richter

Hum Mol Genet· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis